Podcast: Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks Pricing

In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through the last two weeks in the psychedelics field, including these stories:

• Early Notes from The Psychedelic Healthcare Forum
• FDA Floats an Ibogaine Trial Design, Asks Field for Input
• Compass Talks Pricing, Label and a Slow Launch
• New Mexico Nears Medical Psilocybin Launch
• Six More Potential Psychedelic Brand Names